1-9 of 9
Mei La
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Clinical Trials & Observations
Yousif Matloub, Bruce C. Bostrom, Stephen P. Hunger, Linda C. Stork, Anne Angiolillo, Harland Sather, Mei La, Julie M. Gastier-Foster, Nyla A. Heerema, Scott Sailer, Patrick J. Buckley, Blythe Thomson, Catherine Cole, James B. Nachman, Gregory Reaman, Naomi Winick, William L. Carroll, Meenakshi Devidas, Paul S. Gaynon
Journal: Blood
Blood (2011) 118 (2): 243–251.
https://doi.org/10.1182/blood-2010-12-322909
Published: 2011
Journal Articles

Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group

Clinical Trials & Observations
David R. Freyer, Meenakshi Devidas, Mei La, William L. Carroll, Paul S. Gaynon, Stephen P. Hunger, Nita L. Seibel
Journal: Blood
Blood (2011) 117 (11): 3010–3015.
https://doi.org/10.1182/blood-2010-07-294678
Published: 2011
Includes: Supplemental data
Journal Articles

Germline Genetic Variation and Treatment Response on CCG-1891

Dana Sepe, MD, Thomas McWilliams, Jinbo Chen, PhD, Aaron Kershenbaum, PhD, Huaqing Zhao, Mei La, Meenakshi Davidas, PhD, Beverly Lange, MD, Timothy R. Rebbeck, PhD, Richard Aplenc, MD
Journal: Blood
Blood (2010) 116 (21): 2711.
https://doi.org/10.1182/blood.V116.21.2711.2711
Published: 2010
Journal Articles

Children with Down Syndrome (DS) and NCI Standard Risk (SR) Acute Lymphoblastic Leukemia (ALL) Have a Superior Five-Year Event-Free Survival (EFS) When Treated with Escalating Intravenous Methotrexate on the Children's Cancer Group (CCG) Study 1991

Yousif Matloub, MD, Bruce C. Bostrom, MD, Stephen Hunger, MD, Anne Angiolillo, MD, Meenakshi Devidas, PhD, Mei La, Nyla A. Heerema, Ph.D., Naomi Winick, MD, James Nachman, MD, Harland Sather, PhD, William L. Carroll, MD, Paul S Gaynon, MD
Journal: Blood
Blood (2010) 116 (21): 497.
https://doi.org/10.1182/blood.V116.21.497.497
Published: 2010
Journal Articles

Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial

Clinical Trials & Observations
Linda C. Stork, Yousif Matloub, Emmett Broxson, Mei La, Rochelle Yanofsky, Harland Sather, Ray Hutchinson, Nyla A. Heerema, April D. Sorrell, Margaret Masterson, Archie Bleyer, Paul S. Gaynon
Journal: Blood
Blood (2010) 115 (14): 2740–2748.
https://doi.org/10.1182/blood-2009-07-230656
Published: 2010
Journal Articles

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

Clinical Trials & Observations
Wendy Stock, Mei La, Ben Sanford, Clara D. Bloomfield, James W. Vardiman, Paul Gaynon, Richard A. Larson, James Nachman
Journal: Blood
Blood (2008) 112 (5): 1646–1654.
https://doi.org/10.1182/blood-2008-01-130237
Published: 2008
Journal Articles

Improved Outcome of Children with Down Syndrome (DS) and High Risk Acute Lymphocytic Leukemia (HR-ALL): A Report of CCG-1961.

Caroline Hastings, James A. Whitlock, Mei La, Nita Seibel
Journal: Blood
Blood (2007) 110 (11): 586.
https://doi.org/10.1182/blood.V110.11.586.586
Published: 2007
Journal Articles

Failure of Asparagine (ASN) Depletion, Not Inadequate Asparaginase (ASNase) Activity, Predicts Relapse in Standard Risk (SR) Childhood Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group (COG) Report.

Vassilios I. Avramis, PhD, John S. Holcenberg, MD, Alice G. Ettinger, RN, Linda C. Stork, MD, Mei La, MS, Paul S. Gaynon, MD
Journal: Blood
Blood (2007) 110 (11): 588.
https://doi.org/10.1182/blood.V110.11.588.588
Published: 2007
Journal Articles

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group

Clinical Trials & Observations
Yousif Matloub, Susan Lindemulder, Paul S. Gaynon, Harland Sather, Mei La, Emmett Broxson, Rochelle Yanofsky, Raymond Hutchinson, Nyla A. Heerema, James Nachman, Marilyn Blake, Linda M. Wells, April D. Sorrell, Margaret Masterson, John F. Kelleher, Linda C. Stork
Journal: Blood
Blood (2006) 108 (4): 1165–1173.
https://doi.org/10.1182/blood-2005-12-011809
Published: 2006